InMed Reports Fiscal 2027 Results and Updates Mentari Merger
InMed Pharmaceuticals reported its first quarter fiscal 2027 financial results and is advancing its proposed merger with Mentari Therapeutics, which is expected to close in Q4 2026. The company will also hold an annual general and special meeting on November 4, 2026, to secure shareholder approval for the transaction.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed